Lumen Bioscience, Inc. — Form D
Lumen Bioscience, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-29. The offering totals $50.5M. Industry: Biotechnology.
Offering
- Filed: 2022-06-29
- Form: D
- Accession: 0001703612-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.5M
- Remaining: $50.5M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450591
Issuer
- Name: Lumen Bioscience, Inc.
- CIK: 0001703612
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1441 NORTH 34TH STREET, SUITE 300, SEATTLE, WA, 98103
- Phone: 206-899-1904
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Don Schlosser | Executive Officer | Seattle, WA |
| James Roberts | Director | Dallas, TX |
| James Roberts | Executive Officer | Dallas, TX |
| James Roberts | Promoter | Dallas, TX |
| Erik Anderson | Director | Issaquah, WA |
| Marcos Milla | Director | La Jolla, CA |
| Ed Schlect | Director | Seattle, WA |
| Craig Behnke | Executive Officer | Seattle, WA |
| John Morrow | Executive Officer | ST. PETERSBURG, FL |
| Robert Carlson | Director | Seattle, WA |
| Mark Litton | Director | Seattle, WA |
| Eric Orse | Executive Officer | Seattle, WA |
| Brian Finrow | Director | Seattle, WA |
| Brian Finrow | Executive Officer | Seattle, WA |
| Brian Finrow | Promoter | Seattle, WA |
Other filings by this issuer (4)
More